麻豆传媒

Cardiology >

Myocardial Infarction

News, opinions and meeting coverage in cardiology.

FDA Rejects Canakinumab in CVD Prevention

CANTOS data not enough to expand indication

Morning Break: Human Side of Addiction; Eyeing Da Vinci's Genius; No CV Indication for Ilaris

Health news and commentary from around the Web gathered by the 麻豆传媒 staff

FDA Approves Rivaroxaban for CV Prevention in CAD, PAD

Low dose to arrive in the U.S. next week

Heart Benefit Seen with GLP-1 RA Albiglutide

Significant reduction in myocardial infarctions; will drug be brought back to market?

TCT: IVUS Tops Angiography Guidance for Stent Implantation

Intravascular ultrasound-guidance cut TVF in all-comers trial

TCT: 10 Years On, Surgery for Left Main Disease Edges Stenting

Separate studies suggest some groups do better with CABG

Vascepa Prevents Major Cardiovascular Events, Says Manufacturer

Big win for proprietary fish-oil product

TCT: Studies Suggest Thin May Not Always Be in for DES

Resolute Onyx, BioFreedom on par with ultra-thin Orsiro stent

TCT: Orsiro Stent has Its Day in BIOFLOW V Trial

Does this mean superiority over Xience?

10-Minute Headstart for the Cath Lab Helps in STEMI Emergencies

Quicker revascularization, possibly better survival seen in registry

Pre-Hospital Laryngeal Tube Ups Cardiac Arrest Survival

Trials cast doubt on endotracheal intubation as preferred treatment

ESC: DCB Works for De Novo Stenoses in Small Coronary Vessels

Established for in-stent restenosis, DCBs make their way to native coronary arteries

ESC: ACS Outcomes the Same for High-Sensitivity vs Standard Troponin Tests

No reduction in later events with more sensitive assay

ESC: MI Redefined in International Guidelines

Fourth "Universal Definition of Myocardial Infarction" issued

ESC: Short DAPT with Ticagrelor Doesn't Improve Outcomes

Antiplatelet strategy safe, but misses superiority to standard DAPT after stenting

ESC: CTA for Stable Chest Pain Prevents More MIs Long Term

Better than stress ECG as first-line test, SCOT-HEART investigators say

Cath Lab Recap: Intracardiac Echo; Safe Late Lumen Loss Limit

Interventional cardiology news to note

TAVR Growing Even in Younger Age Groups

National trends seen across ages through 2015 likely have continued

Antidepressant After ACS May Help Long-Term Cardiac Outcomes

Extended trial follow-up shows advantages where prior RCTs have not

Study: Epinephrine May Not Be Best Choice for Cardiogenic Shock in MI

Associated with higher rates of refractory shock than with norepinephrine

Studies on Post-STEMI Tx Seen Marred by Faulty Endpoint

MSI calculated from edema-based AAR problematic, researchers say

Select STEMI Patients Gain Microvascular Boost with Novel Device

Infarct sizes also smaller with PCI add-on

Pilot Study Hints at IABP Benefit for Some STEMI Patients

Trend toward better prognosis in those with persistent post-PCI ischemia

LAMA Tx Didn't Up Heart Disease Risk in COPD

Cardiovascular outcomes similar to placebo-treated patients

Ticagrelor Linked to Sleep Apnea, Dyspnea

Breathing problems particularly common with this particular antiplatelet

Why Call for Doctor on the Plane If They're Just Going to Ignore You?

Milton Packer recounts two very different experiences

Troponin Predicts Mortality in Inflammatory Arthritis

High levels associated with all-cause and cardiovascular death

Vibrating ICD/CRT-D; Pradaxa Reversal Agent; Prevention Bonanza

Recent developments of interest in cardiovascular medicine

Going Generic OK for Clopidogrel

Non-inferiority achieved for ACS survivors in Canadian study

Novel Drug Reverses Anticoagulation in Emergencies

Andexanet stops 90% of action of factor Xa inhibitors

Mixed Results for Shorter DAPT in ACS Patients

Shorter regimen non-inferior to standard care, but not ready for prime-time

Perioperative Beta Blockers Trade Fewer MIs for More Deaths

Issue of safety highlighted again in POISE analysis

P2Y12 Tx Subsidy Yields Positive Response from Docs, Patients

Ticagrelor vouchers boost use, but clinical outcomes unchanged

NOAC Helps Stem Consequences of Cardiac Damage After Surgery

Fewer major vascular events with therapy after myocardial injury

Ticagrelor Can Safely Follow Lytic Tx for STEMI

Bleeding similar upon delayed adminstration of ticagrelor versus clopidogrel

Mixed Results with LifeVest for Post-MI Prevention

No reduction in sudden deaths, but benefit in secondary outcomes with external defibrillator

Tweaking DES May Not Help High Bleed-Risk Patients

Thinner strut, biodegradable polymer not better in trial subanalysis

Can We Compare Monthly Cramps to Heart Attack? (Dr. Jen Gunter)

No, for a couple of reasons

BVS Development Continues with Cautious Optimism

Thinner struts prioritized; other experimental features tested

Turning on the Tunes Amps Up Stress Test Times

Patients ran longer to the sound of Latin beats in pilot trial

鈥�

10